Drug delivery and nanoparticles:applications and hazards

Area of Science:

• Nanomedicine
• Pharmaceutical Sciences
• Toxicology

Background:

• Nanotechnology is rapidly advancing drug delivery systems, particularly for cancer therapy.
• While nanoparticles can reduce drug toxicity, their inherent risks are increasingly recognized.
• Conventional toxicity assessments may not fully capture nanoparticle-specific hazards.

Purpose of the Study:

• To provide an overview of current nanoparticle drug delivery systems.
• To highlight the unique toxicological challenges posed by nanoparticles.
• To discuss the necessity of updated safety evaluation methods for nanomedicines.

Main Methods:

• Review of existing literature on nanoparticle drug delivery.
• Analysis of particle toxicology principles, drawing parallels with inhalation toxicity.
• Examination of nanoparticle interactions with biological barriers and cellular components.

Main Results:

• Nanoparticles offer unique advantages, including crossing biological barriers like the blood-brain barrier.
• Particle composition significantly influences tissue interaction and potential toxicity.
• Current safety requirements may be insufficient for comprehensive nanoparticle risk assessment.

Conclusions:

• Nanoparticle drug delivery holds significant promise but requires careful consideration of associated risks.
• Adapting principles from particle toxicology is crucial for evaluating nanoparticle safety.
• Additional, more specific testing is likely needed to ensure the safety of nanomedicines.